Benecchi Christopher

CIK 00018814031 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001881403

Recent Transactions

23 trades

Disposition to Issuer
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-31−40,000→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Common Stock
2025-07-31−36,375→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-31−12,500→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Common Stock
2025-07-31−28,053→ 0 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2025-04-10$6.91/sh−793→ 46,377 total
Award
Sage Therapeutics, Inc.
Common Stock
2025-04-10+2,712→ 49,089 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2025-04-10$6.91/sh−661→ 48,428 total
Award
Sage Therapeutics, Inc.
Common Stock
2025-04-10+3,255→ 47,170 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2025-02-13$7.18/sh−822→ 43,915 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2025-01-16+40,000→ 40,000 total
Award
Sage Therapeutics, Inc.
Common Stock
2025-01-16+20,000→ 44,737 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to buy)
2024-11-01+12,500→ 12,500 total
Award
Sage Therapeutics, Inc.
Common Stock
2024-11-01+6,250→ 24,737 total
Award
Sage Therapeutics, Inc.
Common Stock
2024-08-05+16,200→ 23,242 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2024-08-05$8.96/sh−4,755→ 18,487 total
Award
Sage Therapeutics, Inc.
Common Stock
2024-02-13+13,500→ 19,430 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-13+27,000→ 27,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-02-13+20,900→ 20,900 total
Award
Sage Therapeutics, Inc.
Common Stock
2023-02-03+6,750→ 7,379 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2023-02-03$44.16/sh−2,119→ 5,260 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2022-06-16+9,500→ 9,500 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-11+11,400→ 11,400 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-10-01+45,000→ 45,000 total

Companies

Sage Therapeutics, Inc.
Chief Operating Officer

Recent Filings

Address

C/O SAGE THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY

CAMBRIDGE, MA, 02142

View on SEC.gov